Martin Christopher Nathan 4
4 · Edgewise Therapeutics, Inc. · Filed Nov 24, 2025
Insider Transaction Report
Form 4
Martin Christopher Nathan
Director
Transactions
- Award
Stock Options (Right to buy)
2025-11-19+45,150→ 45,150 totalExercise: $22.34Exp: 2035-11-19→ Common Stock (45,150 underlying)
Footnotes (1)
- [F1]1/36th of the shares subject to the option vest each month beginning on December 19, 2025, subject to the Reporting Person continuing as a service provider through each vest date.